The global hydroxyzine market size is calculated at USD 833 million in 2024 and is predicted to reach around USD 1,450 million by 2034, expanding at a CAGR of 5.7% from 2024 to 2034.
Hydroxyzine is used to help manage tension and anxiety brought on by mental and neurological disorders. Additionally, it can help induce sleep and manage anxiety before surgery. Atopic and contact dermatoses and chronic urticaria are among the allergic disorders for which this medication is used to alleviate symptoms. One type of antihistamine is hydroxyzine. It functions by blocking the body's production of a chemical called histamine.
Hydroxyzine's antihistamine qualities promote its use in treating several allergic disorders. Due to environmental changes, pollution, and other reasons, allergy illnesses are on the rise. As a result, there will likely be a significant need for safe and efficient remedies that lessen itching and rashes.
North America dominated the hydroxyzine market in 2023 because of the patient population's high level of treatment knowledge, the healthcare system, the early uptake of new drugs, and the growing number of pharmaceutical corporations' business alliances with contract research organizations in developing nations. The main cause for concern is the rising incidence of atopic dermatitis worldwide, particularly in the US.
Published by Ajit Bansod
